{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:53:04Z","timestamp":1791593584294,"version":"4.3.4"},"reference-count":238,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":111,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171243"],"award-info":[{"award-number":["82171243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Military Medical Research"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.mmr.2026.100032","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:55:03Z","timestamp":1777294503000},"page":"100032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["E3 ubiquitin ligases in neurodegenerative diseases"],"prefix":"10.1016","volume":"13","author":[{"given":"Duan Lu","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuchen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie H","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Collaborators","year":"2022","journal-title":"Lancet Public Health"},{"issue":"5","key":"10.1016\/j.mmr.2026.100032_bib2","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1007\/s12035-018-1334-z","article-title":"Cellular proteostasis in neurodegeneration","volume":"56","author":"Kurtishi","year":"2019","journal-title":"Mol Neurobiol"},{"issue":"364","key":"10.1016\/j.mmr.2026.100032_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2074","article-title":"Neurodegeneration: from cellular concepts to clinical applications","volume":"8","author":"Katsnelson","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mmr.2026.100032_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev-cellbio-100617-062636","article-title":"Intercellular spread of protein aggregates in neurodegenerative disease","volume":"34","author":"Davis","year":"2018","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41593-020-00778-1","article-title":"Gene-based therapies for neurodegenerative diseases","volume":"24","author":"Sun","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.mmr.2026.100032_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102270","article-title":"Amyloid beta, tau, and alpha-synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases","volume":"214","author":"Sengupta","year":"2022","journal-title":"Prog Neurobiol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100032_bib7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.stem.2023.03.017","article-title":"Advancing cell therapy for neurodegenerative diseases","volume":"30","author":"Temple","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib8","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.7150\/thno.83066","article-title":"New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs)","volume":"13","author":"Palanisamy","year":"2023","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/fn.2020.96707","article-title":"What causes neurodegenerative disease?","volume":"58","author":"Armstrong","year":"2020","journal-title":"Folia Neuropathol"},{"issue":"17","key":"10.1016\/j.mmr.2026.100032_bib10","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1089\/ars.2013.5802","article-title":"The ubiquitin-proteasome system in neurodegeneration","volume":"21","author":"Mckinnon","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"10.1016\/j.mmr.2026.100032_bib11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s10495-010-0466-z","article-title":"Ubiquitin\/proteasome pathway impairment in neurodegeneration: therapeutic implications","volume":"15","author":"Huang","year":"2010","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/ijms25020967","article-title":"Neurodegenerative disease: from molecular basis to therapy","volume":"25","author":"Ricci","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.mmr.2026.100032_bib13","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.3390\/molecules27196515","article-title":"Discovery of E3 ligase ligands for target protein degradation","volume":"27","author":"Lee","year":"2022","journal-title":"Molecules"},{"issue":"Pt B","key":"10.1016\/j.mmr.2026.100032_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.arr.2015.07.009","article-title":"Selective multifaceted E3 ubiquitin ligases barricade extreme defense: Potential therapeutic targets for neurodegeneration and ageing","volume":"24","author":"Upadhyay","year":"2015","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrm.2017.83","article-title":"Ubiquitylation at the crossroads of development and disease","volume":"19","author":"Rape","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.mmr.2026.100032_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101203","article-title":"The dialogue between the ubiquitin-proteasome system and autophagy: implications in ageing","volume":"64","author":"Sun-Wang","year":"2020","journal-title":"Ageing Res Rev"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tig.2020.09.005","article-title":"Trash talk: mammalian proteasome regulation at the transcriptional level","volume":"37","author":"Kamber Kaya","year":"2021","journal-title":"Trends Genet"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s43556-021-00043-2","article-title":"E3 ubiquitin ligases: styles, structures and functions","volume":"2","author":"Yang","year":"2021","journal-title":"Mol Biomed"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41419-019-2142-8","article-title":"The many substrates and functions of NEDD4-1","volume":"10","author":"Huang","year":"2019","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41418-020-00676-w","article-title":"Met1-linked ubiquitin signalling in health and disease: inflammation, immunity, cancer, and beyond","volume":"28","author":"Jahan","year":"2021","journal-title":"Cell Death Differ"},{"issue":"5","key":"10.1016\/j.mmr.2026.100032_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.molcel.2015.05.006","article-title":"Quantitative proteomic atlas of ubiquitination and acetylation in the DNA damage response","volume":"59","author":"Elia","year":"2015","journal-title":"Mol Cell"},{"issue":"193","key":"10.1016\/j.mmr.2026.100032_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.24976\/Discov.Med.202537193.18","article-title":"The ubiquitin code in disease pathogenesis and progression: composition, characteristics and its potential as a therapeutic target","volume":"37","author":"Lee","year":"2025","journal-title":"Discov Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-020-00245-6","article-title":"Beyond K48 and K63: non-canonical protein ubiquitination","volume":"26","author":"Tracz","year":"2021","journal-title":"Cell Mol Biol Lett"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib25","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.tibs.2022.04.003","article-title":"Assembly and function of branched ubiquitin chains","volume":"47","author":"Kolla","year":"2022","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.it.2021.12.005","article-title":"K63 ubiquitination in immune signaling","volume":"43","author":"Madiraju","year":"2022","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41420-022-01204-0","article-title":"Role of K63-linked ubiquitination in cancer","volume":"8","author":"Cao","year":"2022","journal-title":"Cell Death Discov"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/genes6030451","article-title":"Regulation of unperturbed DNA replication by ubiquitylation","volume":"6","author":"Moreno","year":"2015","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41421-020-00237-y","article-title":"Emerging functions of branched ubiquitin chains","volume":"7","author":"French","year":"2021","journal-title":"Cell Discov"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s42003-022-03060-1","article-title":"Non-proteolytic ubiquitylation in cellular signaling and human disease","volume":"5","author":"Liao","year":"2022","journal-title":"Commun Biol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100032_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004898","article-title":"Non-degradative ubiquitination of protein kinases","volume":"12","author":"Ball","year":"2016","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100032_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.222","article-title":"DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161\/164 residues","volume":"8","author":"Glorian","year":"2017","journal-title":"Cell Death Dis"},{"issue":"13","key":"10.1016\/j.mmr.2026.100032_bib33","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1074\/jbc.R800038200","article-title":"Role of non-degradative ubiquitination in interleukin-1 and toll-like receptor signaling","volume":"284","author":"Keating","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib34","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1038\/s41467-025-57384-7","article-title":"APC\/C-mediated ubiquitylation of extranucleosomal histone complexes lacking canonical degrons","volume":"16","author":"Skrajna","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2045-3701-1-43","article-title":"Non-degradative ubiquitination in Smad-dependent TGF-\u03b2 signaling","volume":"1","author":"Tang","year":"2011","journal-title":"Cell Biosci"},{"issue":"5","key":"10.1016\/j.mmr.2026.100032_bib36","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tcb.2023.09.001","article-title":"The ubiquitous role of ubiquitination in lipid metabolism","volume":"34","author":"Loix","year":"2024","journal-title":"Trends Cell Biol"},{"issue":"7701","key":"10.1016\/j.mmr.2026.100032_bib37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41586-018-0026-1","article-title":"Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity","volume":"556","author":"Pao","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mmr.2026.100032_bib38","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cell.2018.04.028","article-title":"The eukaryotic proteome is shaped by E3 ubiquitin ligases targeting C-terminal degrons","volume":"173","author":"Koren","year":"2018","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib39","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/cac2.12192","article-title":"Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis","volume":"41","author":"Ji","year":"2021","journal-title":"Cancer Commun (Lond)"},{"issue":"11","key":"10.1016\/j.mmr.2026.100032_bib40","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.mmr.2026.100032_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.206","article-title":"Proteasome inhibitors in cancer therapy","volume":"14","author":"Manasanch","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"21","key":"10.1016\/j.mmr.2026.100032_bib42","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.3390\/molecules26216682","article-title":"Structural diversity of ubiquitin E3 ligase","volume":"26","author":"Toma-Fukai","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.mmr.2026.100032_bib43","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.molcel.2022.02.004","article-title":"How the ends signal the end: regulation by E3 ubiquitin ligases recognizing protein termini","volume":"82","author":"Sherpa","year":"2022","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib44","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41392-022-01152-2","article-title":"The RING finger protein family in health and disease","volume":"7","author":"Cai","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"20","key":"10.1016\/j.mmr.2026.100032_bib45","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.96.20.11364","article-title":"RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination","volume":"96","author":"Lorick","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mmr.2026.100032_bib46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","article-title":"Ubiquitin ligases: structure, function, and regulation","volume":"86","author":"Zheng","year":"2017","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12035-022-03063-3","article-title":"The emerging roles of E3 ligases and DUBs in neurodegenerative diseases","volume":"60","author":"Liu","year":"2023","journal-title":"Mol Neurobiol"},{"issue":"Pt A","key":"10.1016\/j.mmr.2026.100032_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.nbt.2016.12.002","article-title":"Overview of the membrane-associated RING-CH (MARCH) E3 ligase family","volume":"38","author":"Bauer","year":"2017","journal-title":"N Biotechnol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1742-4658.2010.07921.x","article-title":"PA-TM-RING proteins: a new family of endosomal membrane proteins","volume":"278","author":"Erickson","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.mmr.2026.100032_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1287257","article-title":"It's a TRIM-endous view from the top: the varied roles of TRIpartite Motif proteins in brain development and disease","volume":"16","author":"Dudley-Fraser","year":"2023","journal-title":"Front Mol Neurosci"},{"issue":"Pt 3","key":"10.1016\/j.mmr.2026.100032_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1242\/jcs.091777","article-title":"HECT and RING finger families of E3 ubiquitin ligases at a glance","volume":"125","author":"Metzger","year":"2012","journal-title":"J Cell Sci"},{"issue":"26","key":"10.1016\/j.mmr.2026.100032_bib52","doi-asserted-by":"crossref","first-page":"17962","DOI":"10.1074\/jbc.M802283200","article-title":"CHIP targets toxic alpha-Synuclein oligomers for degradation","volume":"283","author":"Tetzlaff","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41467-023-35871-z","article-title":"The unifying catalytic mechanism of the RING-between-RING E3 ubiquitin ligase family","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib54","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1073\/pnas.0610548104","article-title":"Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson\u2019s disease","volume":"104","author":"Beasley","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/j.mmr.2026.100032_bib55","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/emboj.2013.158","article-title":"Compact Parkin only: insights into the structure of an autoinhibited ubiquitin ligase","volume":"32","author":"Byrd","year":"2013","journal-title":"EMBO J"},{"issue":"6139","key":"10.1016\/j.mmr.2026.100032_bib56","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.1237908","article-title":"Structure of parkin reveals mechanisms for ubiquitin ligase activation","volume":"340","author":"Trempe","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000298","article-title":"PINK1 is selectively stabilized on impaired mitochondria to activate Parkin","volume":"8","author":"Narendra","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1016\/j.mmr.2026.100032_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2019.04.029","article-title":"Therapeutic approaches to enhance PINK1\/Parkin mediated mitophagy for the treatment of Parkinson\u2019s disease","volume":"705","author":"Miller","year":"2019","journal-title":"Neurosci Lett"},{"issue":"24","key":"10.1016\/j.mmr.2026.100032_bib59","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1021\/acs.nanolett.3c04150","article-title":"Structural dynamics of E6AP E3 ligase HECT domain and involvement of a flexible hinge loop in the ubiquitin chain synthesis mechanism","volume":"23","author":"Takeda","year":"2023","journal-title":"Nano Lett"},{"issue":"7","key":"10.1016\/j.mmr.2026.100032_bib60","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.228072","article-title":"HECT E3 ubiquitin ligases-emerging insights into their biological roles and disease relevance","volume":"133","author":"Wang","year":"2020","journal-title":"J Cell Sci"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12035-012-8369-3","article-title":"The central theme of Parkinson\u2019s disease: \u03b1-synuclein","volume":"47","author":"Ozansoy","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.mmr.2026.100032_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ceca.2018.05.001","article-title":"To die or not to die SGK1-sensitive ORAI\/STIM in cell survival","volume":"74","author":"Lang","year":"2018","journal-title":"Cell Calcium"},{"issue":"Pt 2","key":"10.1016\/j.mmr.2026.100032_bib63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.semcancer.2020.03.003","article-title":"ITCH as a potential therapeutic target in human cancers","volume":"67","author":"Yin","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021268","article-title":"Study of ubiquitin pathway genes in a french population with amyotrophic lateral sclerosis: focus on HECW1 encoding the E3 ligase NEDL1","volume":"24","author":"Haouari","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mmr.2026.100032_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156271","article-title":"WWP1-SHARP1-C\/EBP\u03b2 positive feedback loop modulates development of metabolic dysfunction-associated steatotic liver disease","volume":"169","author":"Chen","year":"2025","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib66","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00018-016-2139-8","article-title":"Functional and pathological relevance of HERC family proteins: a decade later","volume":"73","author":"Sanchez-Tena","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib67","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2990.2010.01120.x","article-title":"Smad ubiquitination regulatory factor-2 in progressive supranuclear palsy","volume":"37","author":"Nakamura","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100032_bib68","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/ijms23073882","article-title":"The roles of NEDD4 subfamily of HECT E3 ubiquitin ligases in neurodevelopment and neurodegeneration","volume":"23","author":"Haouari","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/jmedgenet-2012-101367","article-title":"Mutation of HERC2 causes developmental delay with Angelman-like features","volume":"50","author":"Harlalka","year":"2013","journal-title":"J Med Genet"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib70","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1074\/jbc.M706620200","article-title":"E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity","volume":"283","author":"Mishra","year":"2008","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.mmr.2026.100032_bib71","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.3390\/cancers12082108","article-title":"The HECT E3 ligase E6AP\/UBE3A as a therapeutic target in cancer and neurological disorders","volume":"12","author":"Owais","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib72","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/15548627.2024.2407709","article-title":"SMURF1 mediates damaged lysosomal homeostasis by ubiquitinating PPP3CB to promote the activation of TFEB","volume":"21","author":"Xia","year":"2025","journal-title":"Autophagy"},{"issue":"7380","key":"10.1016\/j.mmr.2026.100032_bib73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature10726","article-title":"Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons","volume":"481","author":"Huang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mmr.2026.100032_bib74","unstructured":"Kouli A., Torsney K.M., Kuan W.L. Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, Greenland JC, eds. Parkinson\u2019s disease: pathogenesis and clinical aspects. Brisbane (AU); 2018."},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib75","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nat Neurosci"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib76","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S1474-4422(24)00396-X","article-title":"Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment","volume":"23","author":"Krismer","year":"2024","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib77","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.3390\/ijms25094969","article-title":"The enigma of tau protein aggregation: mechanistic insights and future challenges","volume":"25","author":"Zheng","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib78","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and tau in the pathogenesis of Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.mmr.2026.100032_bib79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2016.03.027","article-title":"Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin","volume":"1643","author":"Lin","year":"2016","journal-title":"Brain Res"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib80","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/hmg\/ddac008","article-title":"E3 ligase Smurf1 protects against misfolded SOD1 in neuronal cells by promoting its K63 ubiquitylation and aggresome formation","volume":"31","author":"Dong","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.mmr.2026.100032_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120099","article-title":"Genetic architecture of motor neuron diseases","volume":"434","author":"Chaudhary","year":"2022","journal-title":"J Neurol Sci"},{"issue":"14","key":"10.1016\/j.mmr.2026.100032_bib82","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib83","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1582-4934.2009.00609.x","article-title":"Abeta aggregation and possible implications in Alzheimer\u2019s disease pathogenesis","volume":"13","author":"Bharadwaj","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00018-024-05262-8","article-title":"PRKN-linked familial Parkinson\u2019s disease: cellular and molecular mechanisms of disease-linked variants","volume":"81","author":"Clausen","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib85","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/cells14100680","article-title":"Molecular mechanisms of protein aggregation in ALS-FTD: focus on TDP-43 and cellular protective responses","volume":"14","author":"Verde","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib86","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jnc.13392","article-title":"Altered alpha-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains","volume":"136","author":"Brudek","year":"2016","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib87","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1471-4159.2004.02486.x","article-title":"CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp\/Hsc70","volume":"90","author":"Urushitani","year":"2004","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib88","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.mmr.2026.100032_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/mds.22798","article-title":"The role of parkin in familial and sporadic Parkinson\u2019s disease","volume":"25","author":"Dawson","year":"2010","journal-title":"Mov Disord"},{"issue":"5675","key":"10.1016\/j.mmr.2026.100032_bib90","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.1093891","article-title":"S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function","volume":"304","author":"Chung","year":"2004","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib91","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41531-025-01038-4","article-title":"Formation of seeding-competent alpha-synuclein aggregates in parkin-deficient iPSC-derived human neurons","volume":"11","author":"Schmidt","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib92","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/cells10020283","article-title":"Interaction between Parkin and alpha-synuclein in PARK2-mediated Parkinson\u2019s disease","volume":"10","author":"Madsen","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mmr.2026.100032_bib93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-5-47","article-title":"Parkinson-related parkin reduces alpha-Synuclein phosphorylation in a gene transfer model","volume":"5","author":"Khandelwal","year":"2010","journal-title":"Mol Neurodegener"},{"issue":"5528","key":"10.1016\/j.mmr.2026.100032_bib94","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson\u2019s disease","volume":"293","author":"Shimura","year":"2001","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib95","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm1001-1144","article-title":"Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease","volume":"7","author":"Chung","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.mmr.2026.100032_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120079","article-title":"Proteomics based discovery of Salvia miltiorrhiza Bunge treating Parkinson\u2019s disease through the PINK1\/Parkin pathway","volume":"350","author":"Xu","year":"2025","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100032_bib97","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/md23040175","article-title":"Epicoccin A ameliorates PD-like symptoms in zebrafish: enhancement of PINK1\/Parkin-dependent mitophagy and inhibition of excessive oxidative stress","volume":"23","author":"Ye","year":"2025","journal-title":"Mar Drugs"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib98","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12031-008-9099-x","article-title":"Parkin attenuates wild-type tau modification in the presence of beta-amyloid and alpha-synuclein","volume":"37","author":"Moussa","year":"2009","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.mmr.2026.100032_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156482","article-title":"Curcuma wenyujin extract alleviates cognitive deficits and restrains pyroptosis through PINK1\/Parkin mediated autophagy in Alzheimer\u2019s disease","volume":"139","author":"Qi","year":"2025","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.mmr.2026.100032_bib100","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s11011-020-00587-2","article-title":"beta-Asarone improves learning and memory in Abeta(1-42)-induced Alzheimer\u2019s disease rats by regulating PINK1-Parkin-mediated mitophagy","volume":"35","author":"Han","year":"2020","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.mmr.2026.100032_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113997","article-title":"Tetrahydroxy stilbene glycoside alleviated inflammatory damage by mitophagy via AMPK related PINK1\/Parkin signaling pathway","volume":"177","author":"Gao","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mmr.2026.100032_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114612","article-title":"A novel dual CCK\/ GLP-1 receptor agonist ameliorates cognitive impairment in 5 \u00d7 FAD mice by modulating mitophagy via the PINK1\/Parkin pathway","volume":"154","author":"Luo","year":"2025","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib103","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13041-022-00936-5","article-title":"Impaired mitochondrial accumulation and Lewy pathology in neuron-specific FBXO7-deficient mice","volume":"15","author":"Noda","year":"2022","journal-title":"Mol Brain"},{"issue":"22","key":"10.1016\/j.mmr.2026.100032_bib104","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1093\/hmg\/ddv340","article-title":"F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy","volume":"24","author":"Zhou","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"13","key":"10.1016\/j.mmr.2026.100032_bib105","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.celrep.2017.03.010","article-title":"Enhanced degradation of misfolded proteins promotes tumorigenesis","volume":"18","author":"Chen","year":"2017","journal-title":"Cell Rep"},{"issue":"18","key":"10.1016\/j.mmr.2026.100032_bib106","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798358","article-title":"TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy","volume":"37","author":"Jena","year":"2018","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib107","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.celrep.2018.11.002","article-title":"The E3 ubiquitin ligases TRIM17 and TRIM41 modulate \u03b1-synuclein expression by regulating ZSCAN21","volume":"25","author":"Lassot","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.mmr.2026.100032_bib108","first-page":"5","article-title":"TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau","author":"Rousseaux","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.mmr.2026.100032_bib109","first-page":"7","article-title":"Depleting Trim28 in adult mice is well tolerated and reduces levels of \u03b1-synuclein and tau","author":"Rousseaux","year":"2018","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108418","article-title":"TRIM11 prevents and reverses protein aggregation and rescues a mouse model of Parkinson\u2019s disease","volume":"33","author":"Zhu","year":"2020","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.mmr.2026.100032_bib111","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41418-024-01334-1","article-title":"E3 ubiquitin ligase TRIM31 alleviates dopaminergic neurodegeneration by promoting proteasomal degradation of VDAC1 in Parkinson\u2019s disease model","volume":"31","author":"Zhao","year":"2024","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib112","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ni.3641","article-title":"The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination","volume":"18","author":"Liu","year":"2017","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib113","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41418-021-00874-0","article-title":"The E3 ubiquitin ligase TRIM31 plays a critical role in hypertensive nephropathy by promoting proteasomal degradation of MAP3K7 in the TGF-beta1 signaling pathway","volume":"29","author":"Zhang","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.mmr.2026.100032_bib114","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuint.2017.08.013","article-title":"Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues","volume":"117","author":"Lizama","year":"2018","journal-title":"Neurochem Int"},{"issue":"25","key":"10.1016\/j.mmr.2026.100032_bib115","doi-asserted-by":"crossref","first-page":"23727","DOI":"10.1074\/jbc.M503326200","article-title":"The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways","volume":"280","author":"Shin","year":"2005","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.mmr.2026.100032_bib116","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1073\/pnas.0810123106","article-title":"CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity","volume":"106","author":"Ko","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib117","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1096\/fj.201700011R","article-title":"Drosophila CHIP protects against mitochondrial dysfunction by acting downstream of Pink1 in parallel with Parkin","volume":"31","author":"Chen","year":"2017","journal-title":"Faseb j"},{"issue":"4","key":"10.1016\/j.mmr.2026.100032_bib118","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib119","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-142094","article-title":"Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes","volume":"44","author":"Saidi","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"33","key":"10.1016\/j.mmr.2026.100032_bib120","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1074\/jbc.M116.733626","article-title":"Amyloid precursor protein (APP) may act as a substrate and a recognition unit for CRL4CRBN and Stub1 E3 ligases facilitating ubiquitination of proteins involved in presynaptic functions and neurodegeneration","volume":"291","author":"Del Prete","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mmr.2026.100032_bib121","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.freeradbiomed.2022.12.099","article-title":"KDM1A-mediated upregulation of METTL3 ameliorates Alzheimer\u2019s disease via enhancing autophagic clearance of p-tau through m6A-dependent regulation of STUB1","volume":"195","author":"Tang","year":"2023","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"10.1016\/j.mmr.2026.100032_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168026","article-title":"The E3 ubiquitin ligase, CHIP\/STUB1, inhibits aggregation of phosphorylated proteoforms of microtubule-associated protein tau (MAPT)","volume":"435","author":"Nadel","year":"2023","journal-title":"J Mol Biol"},{"issue":"11","key":"10.1016\/j.mmr.2026.100032_bib123","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41436-020-0899-x","article-title":"Clinical, neuropathological, and genetic characterization of STUB1 variants in cerebellar ataxias: a frequent cause of predominant cognitive impairment","volume":"22","author":"Roux","year":"2020","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.mmr.2026.100032_bib124","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/mds.29352","article-title":"Complex ataxia-dementia phenotype in patients with digenic TBP\/STUB1 spinocerebellar ataxia","volume":"38","author":"Nanetti","year":"2023","journal-title":"Mov Disord"},{"key":"10.1016\/j.mmr.2026.100032_bib125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fncel.2017.00259","article-title":"Gp78 E3 ubiquitin ligase: essential functions and contributions in proteostasis","volume":"11","author":"Joshi","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"8","key":"10.1016\/j.mmr.2026.100032_bib126","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1091\/mbc.e12-08-0607","article-title":"Regulation of mitophagy by the Gp78 E3 ubiquitin ligase","volume":"24","author":"Fu","year":"2013","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.mmr.2026.100032_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1107323","article-title":"Ubiquitin-modifying enzymes in Huntington\u2019s disease","volume":"10","author":"Sap","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"23","key":"10.1016\/j.mmr.2026.100032_bib128","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1016\/j.neuron.2021.09.031","article-title":"TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson\u2019s disease","volume":"109","author":"Seo","year":"2021","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116262","article-title":"Dynamic regulation of the oxidative stress response by the E3 ligase TRIP12","volume":"44","author":"Ingersoll","year":"2025","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib130","first-page":"71","article-title":"Mechanism of lactic acidemia-promoted pulmonary endothelial cells death in sepsis: role for CIRP-ZBP1-PANoptosis pathway","volume":"11","author":"Gong","year":"2024","journal-title":"Mil Med Res"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib131","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1111\/febs.17065","article-title":"Enhanced translocation of TRIM32 to mitochondria sensitizes dopaminergic neuronal cells to apoptosis during stress conditions in Parkinson\u2019s disease","volume":"291","author":"Goyani","year":"2024","journal-title":"FEBS J"},{"issue":"4","key":"10.1016\/j.mmr.2026.100032_bib132","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1007\/s12035-017-0570-y","article-title":"Parkinson\u2019s disease- associated mutant LRRK2-mediated inhibition of miRNA activity is antagonized by TRIM32","volume":"55","author":"Gonzalez-Cano","year":"2018","journal-title":"Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100032_bib133","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1007\/s12035-016-9989-9","article-title":"Expression of the Parkinson\u2019s disease-associated gene alpha-synuclein is regulated by the neuronal cell fate determinant TRIM32","volume":"54","author":"Pavlou","year":"2017","journal-title":"Mol Neurobiol"},{"issue":"6639","key":"10.1016\/j.mmr.2026.100032_bib134","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.abn1366","article-title":"Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models","volume":"379","author":"Mukadam","year":"2023","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.mmr.2026.100032_bib135","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1002\/alz.12913","article-title":"TRIM25 mutation (p.C168*), coding for an E3 ubiquitin ligase, is a cause of early-onset autosomal dominant dementia with amyloid load and parkinsonism","volume":"19","author":"Gomez-Tortosa","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.mmr.2026.100032_bib136","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1474-9726.2010.00632.x","article-title":"SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer\u2019s disease amyloidosis and improves synaptic function","volume":"9","author":"Gong","year":"2010","journal-title":"Aging Cell"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib137","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1074\/jbc.M113.515056","article-title":"F-box only protein 2 (Fbxo2) regulates amyloid precursor protein levels and processing","volume":"289","author":"Atkin","year":"2014","journal-title":"J Biol Chem"},{"issue":"123","key":"10.1016\/j.mmr.2026.100032_bib138","doi-asserted-by":"crossref","first-page":"ra42","DOI":"10.1126\/scisignal.2000751","article-title":"TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy","volume":"3","author":"Shi","year":"2010","journal-title":"Sci Signal"},{"issue":"11","key":"10.1016\/j.mmr.2026.100032_bib139","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1074\/jbc.275.11.7918","article-title":"Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1\u03b2- and tumor necrosis factor-\u03b1 (TNF\u03b1)-dependent, and involves a TNF\u03b1 receptor-associated factor- and NF\u03baB-inducing kinase-dependent signaling mechanism","volume":"275","author":"Akama","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s42003-021-01720-2","article-title":"Mitochondrial ubiquitin ligase alleviates Alzheimer\u2019s disease pathology via blocking the toxic amyloid-beta oligomer generation","volume":"4","author":"Takeda","year":"2021","journal-title":"Commun Biol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100032_bib141","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021836118","article-title":"PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington\u2019s disease","volume":"118","author":"Morozko","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.mmr.2026.100032_bib142","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/mds.28896","article-title":"A PIAS1 protective variant S510G delays polyQ disease onset by modifying protein homeostasis","volume":"37","author":"Lee","year":"2022","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib143","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuron.2016.03.016","article-title":"PIAS1 regulates mutant huntingtin accumulation and Huntington\u2019s disease-associated phenotypes in vivo","volume":"90","author":"Ochaba","year":"2016","journal-title":"Neuron"},{"issue":"20","key":"10.1016\/j.mmr.2026.100032_bib144","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl2036","article-title":"TRIM37 is a primate-specific E3 ligase for Huntingtin and accounts for the striatal degeneration in Huntington\u2019s disease","volume":"10","author":"Qin","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.mmr.2026.100032_bib145","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14405","article-title":"Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington\u2019s disease","volume":"8","author":"Gomez-Pastor","year":"2017","journal-title":"Nat Commun"},{"issue":"51","key":"10.1016\/j.mmr.2026.100032_bib146","doi-asserted-by":"crossref","first-page":"51504","DOI":"10.1074\/jbc.M306347200","article-title":"Siah-1 facilitates ubiquitination and degradation of synphilin-1","volume":"278","author":"Nagano","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.mmr.2026.100032_bib147","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/hmg\/ddm363","article-title":"Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death","volume":"17","author":"Lee","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.mmr.2026.100032_bib148","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jmcb\/mjaa072","article-title":"Haploinsufficiency of the TDP43 ubiquitin E3 ligase RNF220 leads to ALS-like motor neuron defects in the mouse","volume":"13","author":"Ma","year":"2021","journal-title":"J Mol Cell Biol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib149","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12902","article-title":"TDP-43 pathology and functional deficits in wild-type and ALS\/FTD mutant cyclin F mouse models","volume":"49","author":"Van Hummel","year":"2023","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"26","key":"10.1016\/j.mmr.2026.100032_bib150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2501057122","article-title":"Structural mechanism for the recognition of E2F1 by the ubiquitin ligase adaptor cyclin F","volume":"122","author":"Ngoi","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib151","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00018-017-2632-8","article-title":"Pathogenic mutation in the ALS\/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy","volume":"75","author":"Lee","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"14","key":"10.1016\/j.mmr.2026.100032_bib152","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/hmg\/ddad063","article-title":"ALS-linked CCNF variant disrupts motor neuron ubiquitin homeostasis","volume":"32","author":"Farrawell","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib153","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1007\/s12035-023-03355-2","article-title":"The E3 ubiquitin ligase SCF cyclin F promotes sequestosome-1\/p62 insolubility and foci formation and is dysregulated in ALS and FTD pathogenesis","volume":"60","author":"Davidson","year":"2023","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.mmr.2026.100032_bib154","article-title":"Muscle atrophy and motor neuron degeneration in human NEDL1 transgenic mice","volume":"2011","author":"Zhang","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.mmr.2026.100032_bib155","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev-pharmtox-010814-124332","article-title":"Targeting Hsp90\/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases","volume":"55","author":"Pratt","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.mmr.2026.100032_bib156","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neurobiolaging.2021.08.013","article-title":"Enrichment of rare variants in E3 ubiquitin ligase genes in Early onset Parkinson\u2019s disease","volume":"109","author":"Gu","year":"2022","journal-title":"Neurobiol Aging"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005503","article-title":"The Parkinson\u2019s disease-associated protein kinase LRRK2 modulates notch signaling through the endosomal pathway","volume":"11","author":"Imai","year":"2015","journal-title":"PLoS Genet"},{"issue":"22","key":"10.1016\/j.mmr.2026.100032_bib158","doi-asserted-by":"crossref","first-page":"19410","DOI":"10.1074\/jbc.M110.205211","article-title":"Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2","volume":"286","author":"K\u00fchnle","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mmr.2026.100032_bib159","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.semcdb.2021.11.017","article-title":"The HERC proteins and the nervous system","volume":"132","author":"P\u00e9rez-Villegas","year":"2022","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111751","article-title":"Mechanisms of IRF2BPL-related disorders and identification of a potential therapeutic strategy","volume":"41","author":"Sinha Ray","year":"2022","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib161","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl5613","article-title":"Loss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling","volume":"8","author":"Marcogliese","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.mmr.2026.100032_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1426177","article-title":"Novel human neurodevelopmental and neurodegenerative disease associated with IRF2BPL gene variants-mechanisms and therapeutic avenues","volume":"18","author":"Bauersachs","year":"2024","journal-title":"Front Neurosci"},{"issue":"8","key":"10.1016\/j.mmr.2026.100032_bib163","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1111\/epi.17557","article-title":"IRF2BPL: a new genotype for progressive myoclonus epilepsies","volume":"64","author":"Costa","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.mmr.2026.100032_bib164","first-page":"8","article-title":"A mechanism in agrin signaling revealed by a prevalent Rapsyn mutation in congenital myasthenic syndrome","author":"Xing","year":"2019","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.mmr.2026.100032_bib165","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41556-024-01461-4","article-title":"The autophagy adaptor TRIAD3A promotes tau fibrillation by nested phase separation","volume":"26","author":"Zhou","year":"2024","journal-title":"Nat Cell Biol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105108","article-title":"Erratum: the E3 ubiquitin ligase RNF216\/TRIAD3 is a key coordinator of the hypothalamic-pituitary-gonadal axis","volume":"25","author":"George","year":"2022","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib167","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/pcn.13752","article-title":"Copy number variations in RNF216 and postsynaptic membrane-associated genes are associated with bipolar disorder: a case-control study in the Japanese population","volume":"79","author":"Nakatochi","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"issue":"17","key":"10.1016\/j.mmr.2026.100032_bib168","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.0000000000001521","article-title":"RNF216 mutations as a novel cause of autosomal recessive Huntington-like disorder","volume":"84","author":"Santens","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib169","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/ijms26020793","article-title":"HERC1 E3 ubiquitin ligase is necessary for autophagy processes and for the maintenance and homeostasis of vesicles in motor nerve terminals, but not for proteasomal activity","volume":"26","author":"Perez-Castro","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.mmr.2026.100032_bib170","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/mds.29938","article-title":"IRF2BPL-related disorder, causing neurodevelopmental disorder with regression, abnormal movements, loss of speech and seizures (NEDAMSS) is characterized by pathology consistent with DRPLA","volume":"39","author":"Venkateswaran","year":"2024","journal-title":"Mov Disord"},{"issue":"Pt 2","key":"10.1016\/j.mmr.2026.100032_bib171","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semcancer.2020.05.002","article-title":"RBR E3 ubiquitin ligases in tumorigenesis","volume":"67","author":"Wang","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib172","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.4161\/15548627.2014.981792","article-title":"Regulation of autophagy by E3 ubiquitin ligase RNF216 through BECN1 ubiquitination","volume":"10","author":"Xu","year":"2014","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.mmr.2026.100032_bib173","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/mds.29355","article-title":"Atrophin-1 function and dysfunction in dentatorubral-pallidoluysian atrophy","volume":"38","author":"Nowak","year":"2023","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.mmr.2026.100032_bib174","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235925","article-title":"An Angelman syndrome substitution in the HECT E3 ubiquitin ligase C-terminal Lobe of E6AP affects protein stability and activity","volume":"15","author":"Beasley","year":"2020","journal-title":"PLoS One"},{"issue":"40","key":"10.1016\/j.mmr.2026.100032_bib175","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1523\/JNEUROSCI.3001-05.2005","article-title":"CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo","volume":"25","author":"Miller","year":"2005","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib176","doi-asserted-by":"crossref","first-page":"11635","DOI":"10.1074\/jbc.M412042200","article-title":"Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes","volume":"280","author":"Jana","year":"2005","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib177","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41419-020-02953-5","article-title":"CHIP as a therapeutic target for neurological diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib178","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3390\/genes15091164","article-title":"Knockout, knockdown, and the schrodinger paradox: genetic immunity to phenotypic recapitulation in zebrafish","volume":"15","author":"Arana","year":"2024","journal-title":"Genes (Basel)"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib179","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nbd.2010.01.007","article-title":"TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson\u2019s disease and dementia with Lewy bodies","volume":"38","author":"Tanji","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41420-025-02482-0","article-title":"The E3 ligase c-Cbl modulates microglial phenotypes and contributes to Parkinson\u2019s disease pathology","volume":"11","author":"Deng","year":"2025","journal-title":"Cell Death Discov"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib181","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","article-title":"Advancing targeted protein degradation for cancer therapy","volume":"21","author":"Dale","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"49","key":"10.1016\/j.mmr.2026.100032_bib182","doi-asserted-by":"crossref","first-page":"22622","DOI":"10.1021\/jacs.2c09255","article-title":"Bridged proteolysis targeting chimera (PROTAC) enables degradation of undruggable targets","volume":"144","author":"Xiong","year":"2022","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib183","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/acs.jmedchem.8b01025","article-title":"Proline- and arginine-rich peptides as flexible allosteric modulators of human proteasome activity","volume":"62","author":"Gizynska","year":"2019","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103650","article-title":"Discovery of small-molecule positive allosteric modulators of Parkin E3 ligase","volume":"25","author":"Shlevkov","year":"2022","journal-title":"iScience"},{"issue":"17","key":"10.1016\/j.mmr.2026.100032_bib185","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/hmg\/ddz080","article-title":"The landscape of Parkin variants reveals pathogenic mechanisms and therapeutic targets in Parkinson\u2019s disease","volume":"28","author":"Yi","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib186","first-page":"59","article-title":"Targeting mitochondrial quality control: new therapeutic strategies for major diseases","volume":"11","author":"Hong","year":"2024","journal-title":"Mil Med Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib187","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41467-022-28520-4","article-title":"The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system","volume":"13","author":"Ji","year":"2022","journal-title":"Nat Commun"},{"issue":"14","key":"10.1016\/j.mmr.2026.100032_bib188","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.3390\/ijms26146576","article-title":"Targeted degradation technologies utilizing autophagy","volume":"26","author":"Zhou","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib189","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41392-023-01589-z","article-title":"Recent advances in targeting the \"undruggable\" proteins: from drug discovery to clinical trials","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.mmr.2026.100032_bib190","article-title":"Advancing design strategy of PROTACs for cancer therapy","volume":"6","author":"Luo","year":"2025","journal-title":"MedComm (2020)"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib191","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11523-025-01137-5","article-title":"Proteolysis targeting chimera (PROTAC) estrogen receptor degraders for treatment of estrogen receptor-positive advanced breast cancer","volume":"20","author":"Hamilton","year":"2025","journal-title":"Target Oncol"},{"key":"10.1016\/j.mmr.2026.100032_bib192","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejmech.2018.01.063","article-title":"Discovery of a Keap1-dependent peptide PROTAC to knockdown tau by ubiquitination-proteasome degradation pathway","volume":"146","author":"Lu","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"23","key":"10.1016\/j.mmr.2026.100032_bib193","doi-asserted-by":"crossref","first-page":"23926","DOI":"10.1021\/acsomega.5c01241","article-title":"Prodrug strategy for PROTACs: high efficiency and low toxicity","volume":"10","author":"Li","year":"2025","journal-title":"ACS Omega"},{"issue":"14","key":"10.1016\/j.mmr.2026.100032_bib194","doi-asserted-by":"crossref","first-page":"14129","DOI":"10.1021\/acs.jmedchem.5c01818","article-title":"NDA Submission of vepdegestrant (ARV-471) to U.S. FDA: the beginning of a new era of PROTAC degraders","volume":"68","author":"Ma","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.mmr.2026.100032_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114719","article-title":"A comprehensive mechanistic investigation of factors affecting intestinal absorption and bioavailability of two PROTACs in rats","volume":"211","author":"Niessen","year":"2025","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib196","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/jacs.0c10008","article-title":"Development of antibody-based PROTACs for the degradation of the cell-surface immune checkpoint protein PD-L1","volume":"143","author":"Cotton","year":"2021","journal-title":"J Am Chem Soc"},{"issue":"5","key":"10.1016\/j.mmr.2026.100032_bib197","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1021\/acschembio.2c00185","article-title":"Roadmap for optimizing and broadening antibody-based PROTACs for degradation of cell surface proteins","volume":"17","author":"Gramespacher","year":"2022","journal-title":"ACS Chem Biol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib198","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/med.21993","article-title":"Progress in RAS-targeted therapeutic strategies: from small molecule inhibitors to proteolysis targeting chimeras","volume":"44","author":"Lu","year":"2024","journal-title":"Med Res Rev"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib199","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1016\/j.apsb.2024.04.007","article-title":"Characteristic roadmap of linker governs the rational design of PROTACs","volume":"14","author":"Dong","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"21","key":"10.1016\/j.mmr.2026.100032_bib200","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1080\/17568919.2024.2409618","article-title":"A long march for targeted protein degradation in the new era: expanding E3 ligases","volume":"16","author":"Mi","year":"2024","journal-title":"Future Med Chem"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib201","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1016\/j.apsb.2025.06.028","article-title":"Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapy","volume":"15","author":"Jang","year":"2025","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"10.1016\/j.mmr.2026.100032_bib202","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chembiol.2016.02.016","article-title":"Specific knockdown of endogenous tau protein by peptide-directed ubiquitin-proteasome degradation","volume":"23","author":"Chu","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.mmr.2026.100032_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112949","article-title":"PROTACs suppression of GSK-3\u03b2, a crucial kinase in neurodegenerative diseases","volume":"210","author":"Jiang","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"37","key":"10.1016\/j.mmr.2026.100032_bib204","doi-asserted-by":"crossref","first-page":"16930","DOI":"10.1021\/jacs.2c05499","article-title":"Discovery of XL01126: a potent, fast, cooperative, selective, orally bioavailable, and blood-brain barrier penetrant PROTAC degrader of leucine-rich repeat kinase 2","volume":"144","author":"Liu","year":"2022","journal-title":"J Am Chem Soc"},{"issue":"6","key":"10.1016\/j.mmr.2026.100032_bib205","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1021\/acsmedchemlett.0c00192","article-title":"PROTAC compounds targeting alpha-synuclein protein for treating neurogenerative disorders: Alzheimer's and Parkinson\u2019s diseases","volume":"11","author":"Kargbo","year":"2020","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib206","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41467-022-28507-1","article-title":"Defining molecular glues with a dual-nanobody cannabidiol sensor","volume":"13","author":"Cao","year":"2022","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.mmr.2026.100032_bib207","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20070823","article-title":"Cerebellar neurodegeneration in the absence of microRNAs","volume":"204","author":"Schaefer","year":"2007","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib208","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tcb.2012.08.013","article-title":"MicroRNAs and neurodegeneration: role and impact","volume":"23","author":"Abe","year":"2013","journal-title":"Trends Cell Biol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib209","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2174\/0115680266283661240226052054","article-title":"Ginsenoside Rg3: a review of its anticancer mechanisms and potential therapeutic applications","volume":"24","author":"Wu","year":"2024","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.mmr.2026.100032_bib210","article-title":"Discovery of a molecular glue that enhances UPRmt to restore proteostasis via TRKA-GRB2-EVI1-CRLS1 axis","author":"Qi","year":"2021","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib211","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/s41467-021-23597-9","article-title":"UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation","volume":"12","author":"Subramanian","year":"2021","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.mmr.2026.100032_bib212","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.apsb.2020.01.003","article-title":"Small-molecule MDM2\/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives","volume":"10","author":"Fang","year":"2020","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib213","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s11658-021-00293-6","article-title":"Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?","volume":"26","author":"Haronikova","year":"2021","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"10.1016\/j.mmr.2026.100032_bib214","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1021\/acs.jmedchem.3c01007","article-title":"Discovery and preclinical pharmacology of NX-2127, an orally bioavailable degrader of Bruton's tyrosine kinase with immunomodulatory activity for the treatment of patients with B cell malignancies","volume":"67","author":"Robbins","year":"2024","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.mmr.2026.100032_bib215","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","article-title":"Targeted protein degradation: from mechanisms to clinic","volume":"25","author":"Tsai","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"10.1016\/j.mmr.2026.100032_bib216","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay5154","article-title":"Light-induced control of protein destruction by opto-PROTAC","volume":"6","author":"Liu","year":"2020","journal-title":"Sci Adv"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib217","doi-asserted-by":"crossref","DOI":"10.4028\/b-wjQRP6","article-title":"Protein kinase STK24 promotes tumor immune evasion via the AKT-PD-L1 axis","volume":"11","author":"Wang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"10.1016\/j.mmr.2026.100032_bib218","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/antib12030043","article-title":"Proteolysis-targeting chimera (PROTAC) delivery into the brain across the blood-brain barrier","volume":"12","author":"Tashima","year":"2023","journal-title":"Antibodies"},{"issue":"2","key":"10.1016\/j.mmr.2026.100032_bib219","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41557-023-01379-8","article-title":"Proteolysis-targeting chimeras with reduced off-targets","volume":"16","author":"Nguyen","year":"2024","journal-title":"Nat Chem"},{"key":"10.1016\/j.mmr.2026.100032_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112981","article-title":"Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: recent progress and future challenges","volume":"210","author":"Zeng","year":"2021","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.mmr.2026.100032_bib221","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1038\/s41467-025-65481-w","article-title":"Development of a targeted BioPROTAC degrader selective for misfolded SOD1","volume":"16","author":"Chisholm","year":"2025","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.mmr.2026.100032_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00771","article-title":"Targeting the mutant androgen receptor with PROTACs in spinal and bulbar muscular atrophy","volume":"22","author":"Lee","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"1-2","key":"10.1016\/j.mmr.2026.100032_bib223","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14728222.2025.2464173","article-title":"Therapeutic targeting of the polyglutamine androgen receptor in spinal and bulbar muscular atrophy","volume":"29","author":"Sangotra","year":"2025","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"10.1016\/j.mmr.2026.100032_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00732","article-title":"PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models","volume":"22","author":"Sangotra","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"7512","key":"10.1016\/j.mmr.2026.100032_bib225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.mmr.2026.100032_bib226","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1021\/ja209924v","article-title":"Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL\/HIF-1\u03b1 interaction","volume":"134","author":"Buckley","year":"2012","journal-title":"J Am Chem Soc"},{"issue":"12","key":"10.1016\/j.mmr.2026.100032_bib227","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem Soc Rev"},{"issue":"7820","key":"10.1016\/j.mmr.2026.100032_bib228","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"issue":"6776","key":"10.1016\/j.mmr.2026.100032_bib229","doi-asserted-by":"crossref","DOI":"10.1126\/science.adx5094","article-title":"Targeted protein degradation in the transmembrane and extracellular space","volume":"390","author":"Zhu","year":"2025","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.mmr.2026.100032_bib230","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/acschembio.0c00285","article-title":"Antibody-PROTAC conjugates enable HER2-dependent targeted protein degradation of BRD4","volume":"15","author":"Maneiro","year":"2020","journal-title":"ACS Chem Biol"},{"issue":"43","key":"10.1016\/j.mmr.2026.100032_bib231","doi-asserted-by":"crossref","first-page":"23299","DOI":"10.1002\/anie.202107347","article-title":"Aptamer-PROTAC conjugates (APCs) for tumor-specific targeting in breast cancer","volume":"60","author":"He","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.mmr.2026.100032_bib232","article-title":"Induced ubiquitination of the partially disordered estrogen receptor alpha protein via a 14-3-3-directed molecular glue-based PROTAC design","author":"Verhoef","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.mmr.2026.100032_bib233","article-title":"Estrogen receptor \u03b1\/14-3-3 molecular glues as alternative treatment strategy for endocrine resistant breast cancer","author":"Visser","year":"2024","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.mmr.2026.100032_bib234","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202411061","article-title":"Lysosome-targeting protein degradation through endocytosis pathway triggered by polyvalent nano-chimera for AD therapy","volume":"37","author":"Wang","year":"2025","journal-title":"Adv Mater"},{"issue":"8009","key":"10.1016\/j.mmr.2026.100032_bib235","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41586-024-07224-3","article-title":"Proteome-scale discovery of protein degradation and stabilization effectors","volume":"628","author":"Poirson","year":"2024","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.mmr.2026.100032_bib236","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202411869","article-title":"Self-oxygenating PROTAC microneedle for spatiotemporally-confined protein degradation and enhanced glioblastoma therapy","volume":"37","author":"Jiang","year":"2025","journal-title":"Adv Mater"},{"issue":"29","key":"10.1016\/j.mmr.2026.100032_bib237","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202504253","article-title":"Biomimetic hybrid PROTAC nanovesicles block multiple DNA repair pathways to overcome temozolomide resistance against orthotopic glioblastoma","volume":"37","author":"Xu","year":"2025","journal-title":"Adv Mater"},{"issue":"4","key":"10.1016\/j.mmr.2026.100032_bib238","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/2472555221991104","article-title":"Small-molecule degraders beyond PROTACs-challenges and opportunities","volume":"26","author":"Kastl","year":"2021","journal-title":"SLAS Discov"}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2054936926000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2054936926000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:37:19Z","timestamp":1783082239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2054936926000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":238,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2054936926000361"],"URL":"https:\/\/doi.org\/10.1016\/j.mmr.2026.100032","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E3 ubiquitin ligases in neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Military Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mmr.2026.100032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of Military Science Publishing House.","name":"copyright","label":"Copyright"}],"article-number":"100032"}}